Mirum Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Mirum Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Mirum Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mirum Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.4M | 61k | 73.31 |
| 2025-06-30 | $8.2M | 162k | 50.89 |
| 2025-03-31 | $6.7M | 150k | 45.05 |
| 2024-12-31 | $3.1M | 74k | 41.35 |
| 2024-09-30 | $2.5M | 64k | 39.00 |
| 2024-06-30 | $2.1M | 60k | 34.19 |
| 2024-03-31 | $1.0M | 41k | 25.12 |
| 2023-12-31 | $1.2M | 41k | 29.52 |
| 2023-09-30 | $1.2M | 39k | 31.60 |
| 2023-06-30 | $549k | 23k | 24.02 |
| 2023-03-31 | $549k | 23k | 24.02 |
| 2022-12-31 | $393k | 20k | 19.50 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas